Cargando…
Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786126/ https://www.ncbi.nlm.nih.gov/pubmed/33437969 http://dx.doi.org/10.1016/j.xpro.2020.100249 |
_version_ | 1783632564933623808 |
---|---|
author | Bery, Nicolas Favre, Gilles Olichon, Aurélien |
author_facet | Bery, Nicolas Favre, Gilles Olichon, Aurélien |
author_sort | Bery, Nicolas |
collection | PubMed |
description | Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell line. The protocol can be used to study the function of RHOB active conformation in various cellular settings. This protocol can be broadly applied to select any kind of intracellular antibody degraders, regardless of conformational state. For complete details on the use and execution of this protocol, please refer to Bery et al. (2019). |
format | Online Article Text |
id | pubmed-7786126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77861262021-01-11 Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line Bery, Nicolas Favre, Gilles Olichon, Aurélien STAR Protoc Protocol Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell line. The protocol can be used to study the function of RHOB active conformation in various cellular settings. This protocol can be broadly applied to select any kind of intracellular antibody degraders, regardless of conformational state. For complete details on the use and execution of this protocol, please refer to Bery et al. (2019). Elsevier 2020-12-30 /pmc/articles/PMC7786126/ /pubmed/33437969 http://dx.doi.org/10.1016/j.xpro.2020.100249 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Protocol Bery, Nicolas Favre, Gilles Olichon, Aurélien Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
title | Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
title_full | Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
title_fullStr | Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
title_full_unstemmed | Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
title_short | Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
title_sort | protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786126/ https://www.ncbi.nlm.nih.gov/pubmed/33437969 http://dx.doi.org/10.1016/j.xpro.2020.100249 |
work_keys_str_mv | AT berynicolas protocoltoselectconformationspecificintracellularantibodiesfortargetedproteindegradationinanengineeredcellline AT favregilles protocoltoselectconformationspecificintracellularantibodiesfortargetedproteindegradationinanengineeredcellline AT olichonaurelien protocoltoselectconformationspecificintracellularantibodiesfortargetedproteindegradationinanengineeredcellline |